Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals decreased helmet use and increased neurosurgical interventions in Nebraska riders after law repeal, suggesting hidden costs.
BACKGROUND: On January 1, 2024, Nebraska repealed its universal motorcycle helmet law for riders aged ≥21 years with a valid Class M license. We evaluated changes in helmet use, clinical outcomes, and short-term direct institutional costs following repeal. STUDY DESIGN: In this multicenter retrospective cohort study, motorcycle crash patients treated at five ACS-verified Level I-III trauma centers in eastern Nebraska before and after repeal were compared by law era and helmet status. Helmet-use trends were assessed using segmented binomial logistic regression. Cost analyses were restricted to patients with positive direct institutional costs using survivor-only and log-transformed models. RESULTS: Among 467 patients (241 pre-repeal, 226 post-repeal), helmet use declined from 84.2% to 20.4% after repeal (p<0.001). Segmented regression demonstrated an immediate reduction in helmet use after repeal (OR 0.17, 95% CI 0.06-0.44; p<0.001), consistent with adjusted individual-level analysis (aOR 0.04, 95% CI 0.03-0.07; p<0.001). Post-repeal, non-helmeted riders had greater unadjusted head-injury burden and more neurosurgical interventions. After adjustment, non-helmeted status remained independently associated with neurosurgical intervention (aOR 3.10, 95% CI 1.03-9.35; p=0.044), but not BIG score ≥2, severe traumatic brain injury composite, or mortality. Adjusted log-transformed analyses showed lower short-term direct institutional costs among non-helmeted riders (cost ratio 0.68, 95% CI 0.54-0.86; p=0.001), likely reflecting differences in injury patterns and procedural utilization rather than reduced economic burden. CONCLUSIONS: Nebraska's helmet-law repeal was associated with an immediate and sustained reduction in helmet use. Non-helmeted riders had higher adjusted odds of neurosurgical intervention despite similar adjusted severe brain injury and mortality outcomes. Lower short-term institutional costs should not be interpreted as economic neutrality because they exclude downstream rehabilitation, disability, productivity losses, and societal costs.
No takes yet. Share an insight, caveat, or question.
Henry et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: